AmerisourceBergen to pay $260M in case over production of sterile cancer medicines
admin 27th September 2017 Uncategorised 0AmerisourceBergen Wednesday pled guilty to a federal misdemeanor charge and agreed to pay $260 million to lay to rest one piece of a five-year-old Justice Department probe into its sales of millions of prefilled syringes of cancer medications that came from a facility that was never registered with the FDA.
More: AmerisourceBergen to pay 0M in case over production of sterile cancer medicines
Source: fierce